CDKN2A and cancer: p16, encoded by the CDKN2A gene, is a major tumor suppressor protein, highly expressed in senescent cells in in vitro models and inactivated in a variety of human cancers, including 30 to 70% of pediatric or adult high-grade astrocytomas [21,33,40].